Ustekinumab - Janssen Biotech
At a glance
- Drug Originator Centocor; Medarex
- Drug Licenced by Janssen-Cilag; Mitsubishi Tanabe Pharma Corporation
- Drug Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Antiulcers; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Interleukin 12 inhibitors; Interleukin 23 inhibitors
- USA Patent Applicants CENTOCOR ORTHO BIOTECH INC; JANSSEN BIOTECH
- USA Patents 96
- BLAs 2
- International Patents 1,236
Disclaimer